Draft Guidance: Advanced Manufacturing Technologies Designation Program FDA Creates New Advisory Committee for Evaluation of Genetic Metabolic Disease Treatments-2023/12/12

Page: Parallel scientific advice processes and special product types-2025/1/22

Document: List of medicinal products under additional monitoring-2025/2/24

Document: Day 80 assessment report - Non-clinical template with guidance Rev. 03.25 - Revamp-2025/4/1

Document: European Shortages Monitoring Platform (ESMP): Implementation guide for marketing authorisation holders-2025/5/13

Document: Data access to medicinal products for human use - Chapter 5 Annex A: Product data elements accessible by stakeholder group-20205/6/19

Document: Innovation Task Force (ITF) briefing meeting request form-2025/7/24

Document: Medicinal products for human use: monthly figures - July 2025-2025/9/9

Document: Respiporc Flu3 : EPAR - Medicine overview-2025/10/14

Document: Scientific advice and protocol assistance adopted during the CHMP meeting 15-18 September 2025-2025/11/18